The DOI matches its Crossref record; 234 of the 234 references it cites were found in a registry or an index.
Blood Brain Barrier: A Challenge for Effectual Therapy of Brain Tumors
Open accessAbstract
Brain tumors are one of the most formidable diseases of mankind. They have only a fair to poor prognosis and high relapse rate. One of the major causes of extreme difficulty in brain tumor treatment is the presence of blood brain barrier (BBB). BBB comprises different molecular components and transport systems, which in turn create efflux machinery or hindrance for the entry of several drugs in brain. Thus, along with the conventional techniques, successful modification of drug delivery and novel therapeutic strategies are needed to overcome this obstacle for treatment of brain tumors. In this review, we have elucidated some critical insights into the composition and function of BBB and along with it we have discussed the effective methods for delivery of drugs to the brain and therapeutic strategies overcoming the barrier.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Colowick, S. P., Joshi, M. D., Jagannathan, & KAPLAN, N. O. (1966) · Cited by 26,137
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Astrocyte-endothelial interactions at the blood-brain barrier
Abbott, N. J., Rönnbäck, L., & Hansson, E. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1824 · Cited by 5,595
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01494-7 · Cited by 3,515
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280
Pericytes regulate the blood–brain barrier
Armulik, A., Genové, G., Mäe, M., Nisancioglu, M. H., Wallgard, E., Niaudet, C., He, L., Norlin, J., Lindblom, P., Strittmatter, K., et al. (2010) · Nature · doi:10.1038/nature09522 · Cited by 2,843
The blood-brain barrier/neurovascular unit in health and disease
Hawkins, B. T., & Davis, T. P. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.2.4 · Cited by 2,661
FINE STRUCTURAL LOCALIZATION OF A BLOOD-BRAIN BARRIER TO EXOGENOUS PEROXIDASE
Reese, T. S., & Karnovsky, M. J. (1967) · The Journal of Cell Biology · doi:10.1083/jcb.34.1.207 · Cited by 2,629
Occludin: a novel integral membrane protein localizing at tight junctions.
Furuse, M., Hirase, T., Itoh, M., Nagafuchi, A., Yonemura, S., Tsukita, S., & Tsukita, S. (1993) · The Journal of cell biology · doi:10.1083/jcb.123.6.1777 · Cited by 2,580
JUNCTIONS BETWEEN INTIMATELY APPOSED CELL MEMBRANES IN THE VERTEBRATE BRAIN
Brightman, M. W., & Reese, T. S. (1969) · The Journal of Cell Biology · doi:10.1083/jcb.40.3.648 · Cited by 2,471
A multidrug resistance transporter from human MCF-7 breast cancer cells
Doyle, L. A., Yang, W., Abruzzo, L. V., Krogmann, T., Gao, Y., Rishi, A. K., & Ross, D. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15665 · Cited by 2,322
Size-selective loosening of the blood-brain barrier in claudin-5–deficient mice
Nitta, T., Hata, M., Gotoh, S., Seo, Y., Sasaki, H., Hashimoto, N., Furuse, M., & Tsukita, S. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200302070 · Cited by 1,917
Chen, C.-J., Chin, J. E., Ueda, K., Clark, D. P., Pastan, I., Gottesman, M. M., & Roninson, I. B. (1986) · Cell · doi:10.1016/0092-8674(86)90595-7 · Cited by 1,898
A family of drug transporters: the multidrug resistance-associated proteins
Borst, P., Evers, R., Kool, M., & Wijnholds, J. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.16.1295 · Cited by 1,751
Batrakova, E. V., & Kabanov, A. V. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.04.013 · Cited by 1,278
Itoh, M., Furuse, M., Morita, K., Kubota, K., Saitou, M., & Tsukita, S. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.6.1351 · Cited by 1,151
Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)
Austin Doyle, L., & Ross, D. D. (2003) · Oncogene · doi:10.1038/sj.onc.1206938 · Cited by 1,051
Hagenbuch, B., & Meier, P. J. (2004) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s00424-003-1168-y · Cited by 1,019
Hediger, M. A., Romero, M. F., Peng, J.-B., Rolfs, A., Takanaga, H., & Bruford, E. A. (2004) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s00424-003-1192-y · Cited by 985
ABC Multidrug Transporters: Structure, Function and Role in Chemoresistance
Sharom, F. J. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.1.105 · Cited by 973
Thomas, H., & Coley, H. M. (2003) · Cancer Control · doi:10.1177/107327480301000207 · Cited by 931
Miyake, K., Mickley, L. A., Litman, T., Zhan, Z., Robey, R. W., Cristensen, B., Brangi, M., Greenberger, L., Dean, M. C., Fojo, T., et al. (1999) · PubMed · Cited by 929
Mathiisen, T. M., Lehre, K. P., Danbolt, N. C., & Ottersen, O. P. (2010) · Glia · doi:10.1002/glia.20990 · Cited by 921
Neurotransmitters as growth regulatory signals: role of receptors and second messengers
Lauder, J. M. (1993) · Trends in Neurosciences · doi:10.1016/0166-2236(93)90162-f · Cited by 805
Electrical resistance across the blood-brain barrier in anaesthetized rats: a developmental study.
Butt, A. M., Jones, H. C., & Abbott, N. J. (1990) · The Journal of Physiology · doi:10.1113/jphysiol.1990.sp018243 · Cited by 775
Roth, M., Obaidat, A., & Hagenbuch, B. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01724.x · Cited by 767
Monocarboxylate transporters in the central nervous system: distribution, regulation and function
Pierre, K., & Pellerin, L. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03168.x · Cited by 744
The monocarboxylate transporter family—Role and regulation
Halestrap, A. P., & Wilson, M. C. (2012) · IUBMB Life · doi:10.1002/iub.572 · Cited by 741
Reduced permeability in CHO cells as a mechanism of resistance to colchicine
Ling, V., & Thompson, L. H. (1974) · Journal of Cellular Physiology · doi:10.1002/jcp.1040830114 · Cited by 686
Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells.
Roninson, I. B., Chin, J. E., Choi, K. G., Gros, P., Housman, D. E., Fojo, A., Shen, D. W., Gottesman, M. M., & Pastan, I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.12.4538 · Cited by 686
Structure and mechanism of ABC transporter proteins
Hollenstein, K., Dawson, R. J., & Locher, K. P. (2007) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2007.07.003 · Cited by 671
The influence of cytokines on the integrity of the blood-brain barrier in vitro
de Vries, H. E., Blom-Roosemalen, M. C. M., Oosten, M. V., de Boer, A. G., van Berkel, T. J. C., Breimer, D. D., & Kuiper, J. (1996) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00148-4 · Cited by 665
Kinoshita, M., McDannold, N., Jolesz, F. A., & Hynynen, K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604318103 · Cited by 645
Expression Cloning and Characterization of a Novel Multispecific Organic Anion Transporter
Sekine, T., Watanabe, N., Hosoyamada, M., Kanai, Y., & Endou, H. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.30.18526 · Cited by 625
Haskins, J., Gu, L., Wittchen, E. S., Hibbard, J., & Stevenson, B. R. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.141.1.199 · Cited by 599
Mackey, J. R., Mani, R. S., Selner, M., Mowles, D., YOUNG, J., Belt, J. A., Crawford, C. R., & Cass, C. E. (1998) · PubMed · Cited by 599
Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles☆
WONG, H., BENDAYAN, R., RAUTH, A., LI, Y., & WU, X. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.008 · Cited by 578
Blood-brain barrier drug targeting: the future of brain drug development.
Pardridge, W. M. (2003) · Molecular Interventions · doi:10.1124/mi.3.2.90 · Cited by 570
Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer
Dhawan, P. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24543 · Cited by 566
ABC Transporters and the Blood-Brain Barrier
Begley, D. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043384844 · Cited by 545
Drug Transporters in the Central Nervous System: Brain Barriers and Brain Parenchyma Considerations
Lee, G., Dallas, S., Hong, M., & Bendayan, R. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01513-8 · Cited by 539
Rao, V. V., Dahlheimer, J. L., Bardgett, M. E., Snyder, A. Z., Finch, R. A., Sartorelli, A. C., & Piwnica-Worms, D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3900 · Cited by 531
Laske, D. W., Youle, R. J., & Oldfield, E. H. (1997) · Nature Medicine · doi:10.1038/nm1297-1362 · Cited by 525
The SLC22 drug transporter family
Koepsell, H., & Endou, H. (2004) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s00424-003-1089-9 · Cited by 525
The SLC2 family of facilitated hexose and polyol transporters
Uldry, M., & Thorens, B. (2004) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s00424-003-1085-0 · Cited by 501
Junctional adhesion molecules (JAMs): more molecules with dual functions?
Ebnet, K., Suzuki, A., Ohno, S., & Vestweber, D. (2004) · Journal of Cell Science · doi:10.1242/jcs.00930 · Cited by 501
Liebner, S., Fischmann, A., Rascher, G., Duffner, F., Grote, E.-H., Kalbacher, H., & Wolburg, H. (2000) · Acta Neuropathologica · doi:10.1007/s004010000180 · Cited by 491
Kusuhara, H., Sekine, T., Utsunomiya-Tate, N., Tsuda, M., Kojima, R., Cha, S. H., Sugiyama, Y., Kanai, Y., & Endou, H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.19.13675 · Cited by 489
GENETIC ANALYSIS OF THE MULTIDRUG TRANSPORTER
Gottesman, M. M., Hrycyna, C. A., Schoenlein, P. V., Germann, U. A., & Pastan, I. (1995) · Annual Review of Genetics · doi:10.1146/annurev.ge.29.120195.003135 · Cited by 478
The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology
Kottra, G., & Daniel, H. (2004) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s00424-003-1101-4 · Cited by 466
CNS Drug Design Based on Principles of Blood‐Brain Barrier Transport
Pardridge, W. M. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70051781.x · Cited by 460
Cloning and characterization of a novel human pH‐dependent organic cation transporter, OCTN1
Tamai, I., Yabuuchi, H., Nezu, J.-I., Sai, Y., Oku, A., Shimane, M., & Tsuji, A. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01441-5 · Cited by 458
The blood-brain and blood-tumor barriers: A review of strategies for increasing drug delivery
Groothuis, D. R. (2000) · Neuro-Oncology · doi:10.1093/neuonc/2.1.45 · Cited by 456
Wolburg, H., Wolburg-Buchholz, K., Kraus, J., Rascher-Eggstein, G., Liebner, S., Hamm, S., Duffner, F., Grote, E.-H., Risau, W., & Engelhardt, B. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0688-z · Cited by 454
Structure of the Blood–Brain Barrier and Its Role in the Transport of Amino Acids
Hawkins, R. A., O’Kane, R. L., Simpson, I. A., & Viña, J. R. (2006) · The Journal of Nutrition · doi:10.1093/jn/136.1.218s · Cited by 453
Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals
Ying, X., Wen, H., Lu, W.-L., Du, J., Guo, J., Tian, W., Men, Y., Zhang, Y., Li, R.-J., Yang, T.-Y., et al. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.09.020 · Cited by 447
Transporting therapeutics across the blood-brain barrier
Abbott, N. J., & Romero, I. A. (1996) · Molecular Medicine Today · doi:10.1016/1357-4310(96)88720-x · Cited by 447
Kullak-Ublick, G. A., Hagenbuch, B., Stieger, B., Schteingart, C. D., Hofmann, A. F., Wolkoff, A. W., & Meier, P. J. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90588-x · Cited by 428
The concentrative nucleoside transporter family, SLC28
Gray, J. H., Owen, R. P., & Giacomini, K. M. (2004) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s00424-003-1107-y · Cited by 419
Cha, S. H., Sekine, T., Kusuhara, H., Yu, E., Kim, J. Y., Kim, D. K., Sugiyama, Y., Kanai, Y., & Endou, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.6.4507 · Cited by 407
Role of the breast cancer resistance protein (ABCG2) in drug transport
Mao, Q. (2005) · The AAPS Journal · doi:10.1208/aapsj070112 · Cited by 405
Formation of tight junction: determinants of homophilic interaction between classic claudins
Piorntek, J., Winkler, L., Wolburg, H., Müller, S. L., Zuleger, N., Piehl, C., Wiesner, B., Krause, G., & Blasig, I. E. (2008) · The FASEB Journal · doi:10.1096/fj.07-8319com · Cited by 398
Nies, A. T., Jedlitschky, G., König, J., Herold-Mende, C., Steiner, H. H., Schmitt, H.-P., & Keppler, D. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.07.051 · Cited by 379
Jonker, J. W., & Schinkel, A. H. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.053298 · Cited by 372
Blood-Brain Barrier Permeation: Molecular Parameters Governing Passive Diffusion
Fischer, H., Gottschlich, R., & Seelig, A. (1998) · Journal of Membrane Biology · doi:10.1007/s002329900434 · Cited by 371
Capillary Ultrastructure and the Blood-Brain Barrier in Human Malignant Brain Tumors
Long, D. M. (1970) · Journal of Neurosurgery · doi:10.3171/jns.1970.32.2.0127 · Cited by 371
Wu, X., Kekuda, R., Huang, W., Fei, Y.-J., Leibach, F. H., Chen, J., Conway, S. J., & Ganapathy, V. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32776 · Cited by 370
Polymorphisms in Human Organic Anion-transporting Polypeptide 1A2 (OATP1A2)
Lee, W., Glaeser, H., Smith, L. H., Roberts, R. L., Moeckel, G. W., Gervasini, G., Leake, B. F., & Kim, R. B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411092200 · Cited by 365
Influence of the Surface Properties on Nanoparticle-Mediated Transport of Drugs to the Brain
Kreuter, J. (2004) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2003.077 · Cited by 362
Pharmacogenomics of human OATP transporters
König, J., Seithel, A., Gradhand, U., & Fromm, M. F. (2006) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-006-0040-y · Cited by 357
Baldwin, S. A., Yao, S. Y. M., Hyde, R. J., Ng, A. M. L., Foppolo, S., Barnes, K., Ritzel, M. W. L., Cass, C. E., & Young, J. D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414337200 · Cited by 353
Quantitative analysis of the olfactory pathway for drug delivery to the brain
Thorne, R. G., Emory, C. R., Ala, T. A., & Frey, W. H. (1995) · Brain Research · doi:10.1016/0006-8993(95)00637-6 · Cited by 352
Ross, D. D., Yang, W., Abruzzo, L. V., Dalton, W. S., Schneider, E., Lage, H., Dietel, M., Greenberger, L., Cole, S. P. C., & Doyle, L. A. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.5.429 · Cited by 350
n, F. (1943) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-194302000-00025 · Cited by 347
Bröer, S., Rahman, B., Pellegri, G., Pellerin, L., Martin, J.-L., Verleysdonk, S., Hamprecht, B., & Magistretti, P. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.48.30096 · Cited by 346
Identification of multispecific organic anion transporter 2 expressed predominantly in the liver
Sekine, T., Cha, S. H., Tsuda, M., Apiwattanakul, N., Nakajima, N., Kanai, Y., & Endou, H. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00585-7 · Cited by 335
Ando-Akatsuka, Y., Saitou, M., Hirase, T., Kishi, M., Sakakibara, A., Itoh, M., Yonemura, S., Furuse, M., & Tsukita, S. (1996) · The Journal of cell biology · doi:10.1083/jcb.133.1.43 · Cited by 331
Zhang, Y., Zhang, Y.-F., Bryant, J., Charles, A., Boado, R. J., & Pardridge, W. M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0740 · Cited by 330
Kabanov, A. V., Batrakova, E. V., & Miller, D. W. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00176-x · Cited by 325
The multispecific organic anion transporter (OAT) family
Sekine, T., Cha, S. H., & Endou, H. (2000) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s004240000297 · Cited by 323
ORGANIC CATION TRANSPORTERS IN INTESTINE, KIDNEY, LIVER, AND BRAIN
Koepsell, H. (1998) · Annual Review of Physiology · doi:10.1146/annurev.physiol.60.1.243 · Cited by 310
Blood–brain barrier breakdown in septic encephalopathy and brain tumours*
Davies, D. C. (2002) · Journal of Anatomy · doi:10.1046/j.1469-7580.2002.00065.x · Cited by 309
Xenobiotic Transport across Isolated Brain Microvessels Studied by Confocal Microscopy
Miller, D. S., Nobmann, S. N., Gutmann, H., Toeroek, M., Drewe, J., & Fricker, G. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12708-3 · Cited by 307
Petri, B., Bootz, A., Khalansky, A., Hekmatara, T., Müller, R., Uhl, R., Kreuter, J., & Gelperina, S. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.10.015 · Cited by 298
Multidrug Resistance-Associated Proteins: Expression and Function in the Central Nervous System
Dallas, S., Miller, D. S., & Bendayan, R. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.2.3 · Cited by 296
Bronger, H., König, J., Kopplow, K., Steiner, H.-H., Ahmadi, R., Herold-Mende, C., Keppler, D., & Nies, A. T. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1271 · Cited by 295
Vorbrodt, A. W., & Dobrogowska, D. H. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(03)00177-2 · Cited by 293
Sampson, J. H., Archer, G. E., Mitchell, D. A., Heimberger, A. B., Herndon, J. E., Lally-Goss, D., McGehee-Norman, S., Paolino, A., Reardon, D. A., Friedman, A. H., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0124 · Cited by 287
Sweet, D. H., Miller, D. S., Pritchard, J. B., Fujiwara, Y., Beier, D. R., & Nigam, S. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203803200 · Cited by 287
Transport of small molecules through the blood-brain barrier: biology and methodology
Pardridge, W. M. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00003-p · Cited by 279
Aurrand-Lions, M., Johnson-Leger, C., Wong, C., Du Pasquier, L., & Imhof, B. A. (2001) · Blood · doi:10.1182/blood.v98.13.3699 · Cited by 278
Ohashi, R., Tamai, I., Yabuuchi, H., Nezu, J.-I., Oku, A., Sai, Y., Shimane, M., & Tsuji, A. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35167-5 · Cited by 273
Pellerin, L., Halestrap, A. P., & Pierre, K. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20307 · Cited by 270
Identification and Characterization of a Novel Monoamine Transporter in the Human Brain
Engel, K., Zhou, M., & Wang, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407913200 · Cited by 267
Role of OATP Transporters in the Disposition of Drugs
Niemi, M. (2007) · Pharmacogenomics · doi:10.2217/14622416.8.7.787 · Cited by 266
Noninvasive gene targeting to the brain
Shi, N., & Pardridge, W. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.130187497 · Cited by 252
Dhanikula, R. S., Argaw, A., Bouchard, J.-F., & Hildgen, P. (2008) · Molecular Pharmaceutics · doi:10.1021/mp700086j · Cited by 246
Gliki, G., Ebnet, K., Aurrand-Lions, M., Imhof, B. A., & Adams, R. H. (2004) · Nature · doi:10.1038/nature02877 · Cited by 244
Increased penetration of paclitaxel into the brain by inhibition of P-Glycoprotein.
Kemper, E. M., van Zandbergen, A. E., Cleypool, C. G. J., Mos, H. A., Boogerd, W. J., Beijnen, J. H., & van Tellingen, O. (2003) · PubMed · Cited by 243
Roberts, L. M., Black, D. S., Raman, C., Woodford, K., Zhou, M., Haggerty, J. E., Yan, A. T., Cwirla, S. E., & Grindstaff, K. K. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.06.015 · Cited by 238
Use of chlorotoxin for targeting of primary brain tumors.
Soroceanu, L., Gillespie, G. Y., Khazaeli, M. B., & Sontheimer, H. W. (1998) · PubMed · Cited by 237
Active efflux across the blood-brain barrier: Role of the solute carrier family
Kusuhara, H., & Sugiyama, Y. (2005) · NeuroRX · doi:10.1602/neurorx.2.1.73 · Cited by 236
Breast cancer resistance protein (BCRP/ABCG2)
Staud, F., & Pavek, P. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.11.004 · Cited by 232
Eisenblätter, T., Hüwel, S., & Galla, H.-J. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02401-6 · Cited by 232
Lim, K. J., Bisht, S., Bar, E. E., Maitra, A., & Eberhart, C. G. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.11.5.14410 · Cited by 232
Saito, R., Bringas, J. R., McKnight, T. R., Wendland, M. F., Mamot, C., Drummond, D. C., Kirpotin, D. B., Park, J. W., Berger, M. S., & Bankiewicz, K. S. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3631 · Cited by 231
Occludin Phosphorylation in Regulation of Epithelial Tight Junctions
Rao, R. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04054.x · Cited by 231
Chen, H., Zhang, X., Dai, S., Ma, Y., Cui, S., Achilefus, S., & Gu, Y. (2013) · Theranostics · doi:10.7150/thno.6630 · Cited by 226
Crawford, C. R., Patel, D. H., Naeve, C. W., & Belt, J. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.9.5288 · Cited by 222
Chen, Y. N., Mickley, L. A., Schwartz, A. M., Acton, E. M., Hwang, J. L., & Fojo, A. T. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38781-2 · Cited by 221
In Situ Localization of P-glycoprotein (ABCB1) in Human and Rat Brain
Bendayan, R., Ronaldson, P. T., Gingras, D., & Bendayan, M. (2006) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.5a6870.2006 · Cited by 220
Enerson, B. E., & Drewes, L. R. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10389 · Cited by 215
Hyde, R. J., Cass, C. E., Young, J. D., & Baldwin, J. D. S. A. (2001) · Molecular Membrane Biology · doi:10.1080/09687680110033765 · Cited by 214
Op Den Kamp, J. A. F., & Roelofsen, B. (1995) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)89065-9 · Cited by 213
Transcytosis of plasma macromolecules in endothelial cells: A cell biological survey
Simionescu, M., Gafencu, A., & Antohe, F. (2002) · Microscopy Research and Technique · doi:10.1002/jemt.10086 · Cited by 207
Expression and functional characterization of ABCG2 in brain endothelial cells and vessels
Zhang, W., Mojsilovic-Petrovic, J., Andrade, M. F., Zhang, H., Ball, M., & Stanimirovic, D. B. (2003) · The FASEB Journal · doi:10.1096/fj.02-1131fje · Cited by 204
Liebner, S., Kniesel, U., Kalbacher, H., & Wolburg, H. (2000) · European Journal of Cell Biology · doi:10.1078/0171-9335-00101 · Cited by 203
Wu, X., George, R. L., Huang, W., Wang, H., Conway, S. J., Leibach, F. H., & Ganapathy, V. (2000) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(00)00189-9 · Cited by 201
Fenart, L., Casanova, A., Dehouck, B., Duhem, C., Slupek, S., Cecchelli, R., & Betbeder, D. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35204-8 · Cited by 196
Chemotherapy of Brain Tumors: The "Blood-Brain Barrier" Is Not a Factor
Vick, N. A. (1977) · Archives of Neurology · doi:10.1001/archneur.1977.00500210025002 · Cited by 195
Wang, C.-H., Chiou, S.-H., Chou, C.-P., Chen, Y.-C., Huang, Y.-J., & Peng, C.-A. (2011) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2010.06.010 · Cited by 194
Gründemann, D., Babin-Ebell, J., Martel, F., Örding, N., Schmidt, A., & Schömig, E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.16.10408 · Cited by 193
The Organic Anion Transporter (OATP) Family
Mikkaichi, T., Suzuki, T., Tanemoto, M., Ito, S., & Abe, T. (2004) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.19.171 · Cited by 191
Lin, X.-N., Tian, Wei, Feng, Huang, Wang, Ren, & Diao (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s16570 · Cited by 189
A critical evaluation of the principles governing the advantages of intra-arterial infusions
Eckman, W. W., Patlak, C. S., & Fenstermacher, J. D. (1974) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01059765 · Cited by 183
Tumor targeting by covalent conjugation of a natural fatty acid to paclitaxel.
Bradley, M. O., Webb, N. L., Anthony, F. H., Devanesan, P. D., Witman, P. A., Hemamalini, S., Chander, M. C., Baker, S. D., He, L., Horwitz, S. B., et al. (2001) · PubMed · Cited by 180
Schuessler, A., Smith, C., Beagley, L., Boyle, G. M., Rehan, S., Matthews, K., Jones, L., Crough, T., Dasari, V., Klein, K., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0296 · Cited by 179
Dantzig, A. H., Shepard, R. L., Law, K. L., Tabas, L., Pratt, S., Gillespie, J. S., Binkley, S. N., Kuhfeld, M. T., Starling, J. J., & Wrighton, S. A. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)34974-2 · Cited by 179
Matsukado, K., Inamura, T., Nakano, S., Fukui, M., Bartus, R. T., & Black, K. L. (1996) · Neurosurgery · doi:10.1097/00006123-199607000-00025 · Cited by 174
Ceballos, A., Belinchon, M. M., Sanchez-Mendoza, E., Grijota-Martinez, C., Dumitrescu, A. M., Refetoff, S., Morte, B., & Bernal, J. (2009) · Endocrinology · doi:10.1210/en.2008-1616 · Cited by 173
Ronaldson, P. T., & Davis, T. P. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212802002625 · Cited by 172
Nucleoside Transporter Proteins
Molina-Arcas, M., Casado, F., & Pastor-Anglada, M. (2009) · Current Vascular Pharmacology · doi:10.2174/157016109789043892 · Cited by 172
Mori, S., Takanaga, H., Ohtsuki, S., Deguchi, T., Kang, Y.-S., Hosoya, K.-I., & Terasaki, T. (2003) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200304000-00007 · Cited by 171
Pharmacokinetics of liposome-encapsulated anti-tumor drugs
Juliano, R. L., & Stamp, D. (1978) · Biochemical Pharmacology · doi:10.1016/0006-2952(78)90252-6 · Cited by 166
Litman, T., Zeuthen, T., Skovsgaard, T., & Stein, W. D. (1997) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(97)00027-6 · Cited by 164
Huber, R. D., Gao, B., Sidler Pfändler, M.-A., Zhang-Fu, W., Leuthold, S., Hagenbuch, B., Folkers, G., Meier, P. J., & Stieger, B. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00597.2005 · Cited by 164
Li, X.-Y., Zhao, Y., Sun, M.-G., Shi, J.-F., Ju, R.-J., Zhang, C.-X., Li, X.-T., Zhao, W.-Y., Mu, L.-M., Zeng, F., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.03.049 · Cited by 163
Reversal of P-glycoprotein mediated multidrug resistance by novel anthranilamide derivatives
Roe, M., Folkes, A., Ashworth, P., Brumwell, J., Chima, L., Hunjan, S., Pretswell, I., Dangerfield, W., Ryder, H., & Charlton, P. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00030-x · Cited by 163
Wohlfart, S., Khalansky, A. S., Gelperina, S., Maksimenko, O., Bernreuther, C., Glatzel, M., & Kreuter, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019121 · Cited by 162
Tissue concentration of systemically administered antineoplastic agents in human brain tumors
Pitz, M. W., Desai, A., Grossman, S. A., & Blakeley, J. O. (2011) · Journal of Neuro-Oncology · doi:10.1007/s11060-011-0564-y · Cited by 161
Peptide and peptide analog transport systems at the blood?CSF barrier
SMITH, D., JOHANSON, C., & KEEP, R. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.07.008 · Cited by 161
Rosso, L., Brock, C. S., Gallo, J. M., Saleem, A., Price, P. M., Turkheimer, F. E., & Aboagye, E. O. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2356 · Cited by 159
The role of claudin-5 in blood-brain barrier (BBB) and brain metastases (Review)
JIA, W., LU, R., MARTIN, T. A., & JIANG, W. G. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1875 · Cited by 158
Kim, S. S., Rait, A. S., Kim, E. H., Pirollo, K. F., Nishida, M., Farkas, N., Dagata, J. A., & Chang, E. H. (2014) · ACS Nano · doi:10.1021/nn5014484 · Cited by 158
Long-term stabilization in patients with malignant glioma after treatment with liposomal doxorubicin
Fabel, K., Dietrich, J., Hau, P., Wismeth, C., Winner, B., Przywara, S., Steinbrecher, A., Ullrich, W., & Bogdahn, U. (2001) · Cancer · doi:10.1002/1097-0142(20011001)92:7<1936::aid-cncr1712>3.0.co;2-h · Cited by 155
New therapeutic approach for brain tumors: Intranasal delivery of telomerase inhibitor GRN163
Hashizume, R., Ozawa, T., Gryaznov, S. M., Bollen, A. W., Lamborn, K. R., Frey, W. H., & Deen, D. F. (2008) · Neuro-Oncology · doi:10.1215/15228517-2007-052 · Cited by 155
Vector-mediated drug delivery to the brain
Pardridge, W. M. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00087-8 · Cited by 146
Chen, W., Xu, X., Jia, H.-Z., Lei, Q., Luo, G., Cheng, S., Zhuo, R., & Zhang, X. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.07.084 · Cited by 146
Sundaram, M., Yao, S. Y. M., Ingram, J. C., Berry, Z. A., Abidi, F., Cass, C. E., Baldwin, S. A., & Young, J. D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107169200 · Cited by 143
Borlongan, C. V., & Emerich, D. F. (2003) · Brain Research Bulletin · doi:10.1016/s0361-9230(03)00043-1 · Cited by 142
Quantitative Examination of Tissue Concentration Profiles Associated with Microdialysis
Dykstra, K. H., Hsiao, J., Morrison, P. F., Bungay, P. M., Mefford, I. N., Scully, M. M., & Dedrick, R. L. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb09346.x · Cited by 141
Jallouli, Y., Paillard, A., Chang, J., Sevin, E., & Betbeder, D. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.06.023 · Cited by 139
Do anticancer agents reach the tumor target in the human brain?
Donelli, M. G., Zucchetti, M., & D’Incalci, M. (1992) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00686291 · Cited by 139
Magnetic nanoparticles: an emerging technology for malignant brain tumor imaging and therapy
Wankhede, M., Bouras, A., Kaluzová, M., & Hadjipanayis, C. G. (2012) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.12.1 · Cited by 139
Liu, Z., & Liang, X. (2012) · Theranostics · doi:10.7150/thno.4156 · Cited by 138
Occludin expression in microvessels of neoplastic and non‐neoplastic human brain
Papadopoulos, M. C., Saadoun, S., Woodrow, C. J., Davies, D. C., Costa‐Martins, P., Moss, R. F., Krishna, S., & Bell, B. A. (2001) · Neuropathology and Applied Neurobiology · doi:10.1046/j.0305-1846.2001.00341.x · Cited by 137
Organic anion transporters and their implications in pharmacotherapy
Emami Riedmaier, A., Nies, A. T., Schaeffeler, E., & Schwab, M. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.004614 · Cited by 128
Quantitative approaches to in vivo brain microdialysis.
Parsons, L. H., & Justice, J. B. (1994) · PubMed · Cited by 127
Kato, T., Natsume, A., Toda, H., Iwamizu, H., Sugita, T., Hachisu, R., Watanabe, R., Yuki, K., Motomura, K., Bankiewicz, K. S., et al. (2010) · Gene Therapy · doi:10.1038/gt.2010.88 · Cited by 127
Kuo, Y., & Liang, C.-T. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.01.048 · Cited by 125
Loo, T. W., & Clarke, D. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.37.21839 · Cited by 124
Youngblood, G. L., & Sweet, D. H. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00012.2004 · Cited by 124
Wang, F., Jiang, X., & Lu, W. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00341-7 · Cited by 120
Lin, C., Tai, Y., Huang, M., Tsai, Y., Hsu, H., Tzen, K., & Liou, H. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06801.x · Cited by 119
Current Perspectives on Established and Putative Mammalian Oligopeptide Transporters
Herrera‐Ruiz, D., & Knipp, G. T. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10303 · Cited by 116
Solid lipid nanoparticles of temozolomide: Potential reduction of cardial and nephric toxicity
Huang, G., Zhang, N., Bi, X., & Dou, M. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.12.013 · Cited by 114
Regulation of organic cation transport
Ciarimboli, G., & Schlatter, E. (2004) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-004-1355-5 · Cited by 112
Rg, B., Cs, P., & Wr, S. (1977) · PubMed · Cited by 110
In Vivo Gene Transfer by Intravenous Administration of Stable Cationic Lipid/DNA Complex
Hofland, H. E. J., Nagy, D., Liu, J., Spratt, K., Lee, Y., Danos, O., & Sullivan, S. M. (1997) · Pharmaceutical Research · doi:10.1023/a:1012146305040 · Cited by 109
Modulation of Drug Transporters at the Blood-Brain Barrier
Fricker, G., & Miller, D. S. (2004) · Pharmacology · doi:10.1159/000075545 · Cited by 106
Function and expression of somatostatin receptors of the endocrine pancreas
Strowski, M. Z., & Blake, A. D. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.02.007 · Cited by 106
Scatter factor/hepatocyte growth factor (SF/HGF) content and function in human gliomas
Lamszus, K., Laterra, J., Westphal, M., & Rosen, E. M. (1999) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(99)00008-8 · Cited by 105
The entry of antiviral and antiretroviral drugs into the central nervous system
Groothuis, D. R., & Levy, R. M. (1997) · Journal of NeuroVirology · doi:10.3109/13550289709031185 · Cited by 101
van Zuylen, L., Sparreboom, A., van der Gaast, A., van der Burg, M. E., van Beurden, V., Bol, C. J., Woestenborghs, R., Palmer, P. A., & Verweij, J. (2000) · PubMed · Cited by 101
Monte, J. C. M., Nagle, M. A., Eraly, S. A., & Nigám, S. K. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.08.112 · Cited by 100
Use of nanoparticles for drug delivery in glioblastoma multiforme
Jain, K. K. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.4.363 · Cited by 99
Matter, K., & Balda, M. S. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200304039 · Cited by 98
The Role of Blood-Brain Barrier Permeability in Brain Tumor Imaging and Therapeutics
Provenzale, J. M., Mukundan, S., & Dewhirst, M. W. (2005) · American Journal of Roentgenology · doi:10.2214/ajr.185.3.01850763 · Cited by 98
Transferrin-conjugated liposomal system for improved delivery of 5-fluorouracil to brain.
Soni, V., Kohli, D. V., & Jain, S. K. (2008) · Journal of drug targeting · doi:10.1080/10611860701725381 · Cited by 96
Doi, A., Kawabata, S., Iida, K., Yokoyama, K., Kajimoto, Y., Kuroiwa, T., Shirakawa, T., Kirihata, M., Kasaoka, S., Maruyama, K., et al. (2008) · Journal of Neuro-Oncology · doi:10.1007/s11060-008-9522-8 · Cited by 95
Blood-Brain Barrier Transport of Reduced Folic Acid
Wu, D., & Pardridge, W. M. (1999) · Pharmaceutical Research · doi:10.1023/a:1018829920158 · Cited by 94
Ling, Y., Wei, K., Zou, F., & Zhong, S. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.03.047 · Cited by 93
Gupta, B., Levchenko, T. S., & Torchilin, V. P. (2006) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/000000006783980946 · Cited by 92
Fortin, D., Gendron, C., Boudrias, M., & Lapointe‐Garant, M. (2007) · Cancer · doi:10.1002/cncr.22450 · Cited by 91
Chen, P. Y., Ozawa, T., Drummond, D. C., Kalra, A. V., Fitzgerald, J. B., Kirpotin, D. B., Wei, K., Butowski, N. A., Prados, M. D., Berger, M. S., et al. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos305 · Cited by 89
Carl, S. M., Lindley, D. J., Couraud, P. O., Weksler, B. B., Romero, I., Mowery, S. A., & Knipp, G. T. (2010) · Molecular Pharmaceutics · doi:10.1021/mp900178j · Cited by 88
Current Vaccine Trials in Glioblastoma: A Review
Xu, L. W., Chow, K. K. H., Lim, M. K., & Li, G. (2014) · Journal of Immunology Research · doi:10.1155/2014/796856 · Cited by 87
Cabrita, M. A., Baldwin, S. A., Young, J. D., & Cass, C. E. (2002) · Biochemistry and Cell Biology · doi:10.1139/o02-153 · Cited by 87
Emerging therapeutic targets in schwannomas and other merlin-deficient tumors
Ammoun, S., & Hanemann, C. O. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.82 · Cited by 86
Transnasal Delivery of 5-Fluorouracil to the Brain in the Rat
Sakane, T., Yamashita, S., Yata, N., & Sezaki, H. (1999) · Journal of drug targeting · doi:10.3109/10611869909085506 · Cited by 86
Blood–brain Barrier Transport of Non-viral Gene and RNAi Therapeutics
Boado, R. J. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9321-5 · Cited by 85
Smith, K. M., Slugoski, M. D., Loewen, S. K., Ng, A. M. L., Yao, S. Y. M., Chen, X., Karpinski, E., Cass, C. E., Baldwin, S. A., & Young, J. D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m409454200 · Cited by 85
Qian, L., Zheng, J., Wang, K., Tang, Y., Zhang, X., Zhang, H., Huang, F., Pei, Y., & Jiang, Y. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.07.097 · Cited by 85
Lamotrigine is a substrate for OCT1 in brain endothelial cells
Dickens, D., Owen, A., Alfirevic, A., Giannoudis, A., Davies, A., Weksler, B. B., Romero, I. A., Couraud, P., & Pirmohamed, M. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.12.032 · Cited by 84
Inano, A., Sai, Y., Nikaido, H., Hashimoto, N., Asano, M., Tsuji, A., & Tamai, I. (2003) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.371 · Cited by 81
Microdialysis for pharmacokinetic analysis of drug transport to the brain
de Lange, E. C. M., de Boer, B. G., & Breimer, D. D. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00089-1 · Cited by 81
Development of bionanocapsules targeting brain tumors
Tsutsui, Y., Tomizawa, K., Nagita, M., et al. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.06.019 · Cited by 78
Lee, G. S., Babakhanian, K., Ramaswamy, M., Prat, A., Wosik, K., & Bendayan, R. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9244-1 · Cited by 76
Quantitative measurements of capillary transport in human brain tumors by computed tomography
Groothuis, D. R., Vriesendorp, F. J., Kupfer, B., Warnke, P. C., Lapin, G. D., Kuruvilla, A., Vick, N. A., Mikhael, M. A., & Patlak, C. S. (1991) · Annals of Neurology · doi:10.1002/ana.410300411 · Cited by 76
Eibl, H., Jendrossek, V., Erdlenbruch, B., & Lakomek, M. (2000) · Experimental Brain Research · doi:10.1007/s002210000553 · Cited by 75
Cited by
Current Challenges and Opportunities in Treating Glioblastoma
Shergalis, A., Bankhead, A., Luesakul, U., Muangsin, N., & Neamati, N. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014944 · Cited by 849
Karri, V., Schuhmacher, M., & Kumar, V. (2016) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2016.09.016 · Cited by 514
Progress and perspectives on targeting nanoparticles for brain drug delivery
Gao, H. (2016) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.05.013 · Cited by 495
Clinical and molecular aspects of lead toxicity: An update
Mitra, P., Sharma, S., Purohit, P., & Sharma, P. (2017) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2017.1408562 · Cited by 389
Agrawal, M., Ajazuddin, Tripathi, D. K., Saraf, S., Saraf, S., Antimisiaris, S. G., Mourtas, S., Hammarlund-Udenaes, M., & Alexander, A. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.05.019 · Cited by 356
Metadata
- Authors
- Bhowmik, A., Khan, R., & Ghosh, M. K.
- Venue
- BioMed Research International
- Publisher
- Wiley
- Published
- 2015
- Volume
- 2015
- Pages
- 1-20
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- OpenAlex
- W2080182688
- Cited by
- 291
- References
- 234
- FWCI
- 7.47
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.